NASDAQ:ILMN

Illumina News Headlines

$456.16
+0.81 (+0.18 %)
(As of 06/18/2021 05:20 PM ET)
Add
Compare
Today's Range
$450.72
▼
$460.48
50-Day Range
$372.84
▼
$455.35
52-Week Range
$260.42
▼
$555.77
Volume1.08 million shs
Average Volume1.05 million shs
Market Capitalization$66.60 billion
P/E Ratio106.58
Dividend YieldN/A
Beta0.94

Illumina (NASDAQ ILMN) News Headlines Today

SourceHeadline
Illumina (NASDAQ:ILMN) Rating Increased to Inline at Evercore ISIIllumina (NASDAQ:ILMN) Rating Increased to Inline at Evercore ISI
marketbeat.com - June 1 at 7:08 AM
Moderna, Illumina, or China’s Meituan Could Be the Next Tesla - BarronsModerna, Illumina, or China’s Meituan Could Be the Next Tesla - Barron's
barrons.com - June 18 at 6:03 PM
Why Moderna, Illumina, or China’s Meituan Could Be the Next TeslaWhy Moderna, Illumina, or China’s Meituan Could Be the Next Tesla
finance.yahoo.com - June 18 at 6:03 PM
Hedge Funds Are Buying Illumina, Inc. (ILMN) - Yahoo FinanceHedge Funds Are Buying Illumina, Inc. (ILMN) - Yahoo Finance
finance.yahoo.com - June 18 at 7:46 AM
Hedge Funds Are Buying Illumina, Inc. (ILMN)Hedge Funds Are Buying Illumina, Inc. (ILMN)
finance.yahoo.com - June 17 at 12:45 PM
EU antitrust regulators set July 27 deadline for Illumina, Grail deal - ReutersEU antitrust regulators set July 27 deadline for Illumina, Grail deal - Reuters
reuters.com - June 17 at 7:45 AM
EU antitrust regulators set July 27 deadline for Illumina, Grail dealEU antitrust regulators set July 27 deadline for Illumina, Grail deal
finance.yahoo.com - June 17 at 7:45 AM
Illumina Inc. stock falls Tuesday, still outperforms market - MarketWatchIllumina Inc. stock falls Tuesday, still outperforms market - MarketWatch
marketwatch.com - June 15 at 6:29 PM
$1.34 Earnings Per Share Expected for Illumina, Inc. (NASDAQ:ILMN) This Quarter$1.34 Earnings Per Share Expected for Illumina, Inc. (NASDAQ:ILMN) This Quarter
americanbankingnews.com - June 15 at 3:50 PM
Bionano Genomics Appoints Richard Shippy, Former Affymetrix, Illumina and Cradle Executive, as its Chief Business Officer - Yahoo FinanceBionano Genomics Appoints Richard Shippy, Former Affymetrix, Illumina and Cradle Executive, as its Chief Business Officer - Yahoo Finance
finance.yahoo.com - June 15 at 8:28 AM
Bionano Genomics Appoints Richard Shippy, Former Affymetrix, Illumina and Cradle Executive, as its Chief Business Officer - GlobeNewswireBionano Genomics Appoints Richard Shippy, Former Affymetrix, Illumina and Cradle Executive, as its Chief Business Officer - GlobeNewswire
globenewswire.com - June 14 at 2:25 PM
Bionano Genomics Appoints Richard Shippy, Former Affymetrix, Illumina and Cradle Executive, as its Chief Business Officer - StreetInsider.comBionano Genomics Appoints Richard Shippy, Former Affymetrix, Illumina and Cradle Executive, as its Chief Business Officer - StreetInsider.com
streetinsider.com - June 14 at 9:24 AM
Has Illumina Lost Its Shine? - Motley FoolHas Illumina Lost Its Shine? - Motley Fool
fool.com - June 12 at 2:08 PM
Has Illumina Lost Its Shine? - NasdaqHas Illumina Lost Its Shine? - Nasdaq
nasdaq.com - June 12 at 9:07 AM
Has Illumina Lost Its Shine?Has Illumina Lost Its Shine?
finance.yahoo.com - June 12 at 9:07 AM
Illumina, Inc. (ILMN) Francis deSouza Presents at Goldman Sachs 42nd Annual Global Healthcare Conference (Transcript) - Seeking AlphaIllumina, Inc. (ILMN) Francis deSouza Presents at Goldman Sachs 42nd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
seekingalpha.com - June 10 at 7:01 PM
DNA Data Storage Alliance Publishes First White Paper, Launches WebsiteDNA Data Storage Alliance Publishes First White Paper, Launches Website
finance.yahoo.com - June 10 at 9:00 AM
Lets Shine a Light on Illuminas Breakout - RealMoneyLet's Shine a Light on Illumina's Breakout - RealMoney
realmoney.thestreet.com - June 9 at 5:12 PM
Lets Shine a Light on Illuminas BreakoutLet's Shine a Light on Illumina's Breakout
finance.yahoo.com - June 9 at 5:12 PM
Will Illumina Be a Trillion-Dollar Stock by 2035? - Motley FoolWill Illumina Be a Trillion-Dollar Stock by 2035? - Motley Fool
fool.com - June 9 at 7:11 AM
Will Illumina Be a Trillion-Dollar Stock by 2035?Will Illumina Be a Trillion-Dollar Stock by 2035?
fool.com - June 9 at 6:51 AM
Is Illumina (NASDAQ:ILMN) Using Too Much Debt? - NasdaqIs Illumina (NASDAQ:ILMN) Using Too Much Debt? - Nasdaq
nasdaq.com - June 6 at 2:58 PM
Grail launches flagship multi-cancer test as Illumina deal awaits antitrust greenlight - San Francisco Business Times - San Francisco Business TimesGrail launches flagship multi-cancer test as Illumina deal awaits antitrust greenlight - San Francisco Business Times - San Francisco Business Times
bizjournals.com - June 5 at 12:36 AM
Illumina rises as GRAIL presents data from early cancer detection test - Seeking AlphaIllumina rises as GRAIL presents data from early cancer detection test - Seeking Alpha
seekingalpha.com - June 4 at 2:36 PM
This Biotech Just Made History. Will Its Stock Follow?This Biotech Just Made History. Will Its Stock Follow?
finance.yahoo.com - June 4 at 2:36 PM
Global Next Generation Sequencing (NGS) Market Report 2021-2026 Featuring Illumina, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore Technologies & Roche - Yahoo FinanceGlobal Next Generation Sequencing (NGS) Market Report 2021-2026 Featuring Illumina, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore Technologies & Roche - Yahoo Finance
finance.yahoo.com - June 4 at 9:35 AM
2 Winners for a Drug Development Future That Looks Nothing Like the Past2 Winners for a Drug Development Future That Looks Nothing Like the Past
finance.yahoo.com - June 4 at 9:35 AM
Grail Will Begin Selling Its Multi-Cancer Blood Test. It Could Be the Start of a Huge Market.Grail Will Begin Selling Its Multi-Cancer Blood Test. It Could Be the Start of a Huge Market.
finance.yahoo.com - June 4 at 9:35 AM
Government Race Against a Cure - The Wall Street JournalGovernment Race Against a Cure - The Wall Street Journal
wsj.com - June 2 at 7:52 PM
Illumina (ILMN) Expands NIPT Offering With New Collaboration - NasdaqIllumina (ILMN) Expands NIPT Offering With New Collaboration - Nasdaq
nasdaq.com - June 1 at 6:21 PM
Illumina suffers setback as court ruling favors FTC attempt to block Grail acquisition - Seeking AlphaIllumina suffers setback as court ruling favors FTC attempt to block Grail acquisition - Seeking Alpha
seekingalpha.com - June 1 at 1:21 PM
Illumina accuses US regulators of time-wasting over $8bn Grail deal - Financial TimesIllumina accuses US regulators of time-wasting over $8bn Grail deal - Financial Times
ft.com - June 1 at 8:20 AM
Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis - Business WireIllumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis - Business Wire
businesswire.com - June 1 at 8:20 AM
Illumina accuses US regulators of time-wasting over $8bn Grail dealIllumina accuses US regulators of time-wasting over $8bn Grail deal
finance.yahoo.com - June 1 at 8:20 AM
Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders DiagnosisIllumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis
finance.yahoo.com - June 1 at 8:20 AM
Illumina (ILMN) Expands NIPT Offering With New CollaborationIllumina (ILMN) Expands NIPT Offering With New Collaboration
finance.yahoo.com - June 1 at 8:20 AM
Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand - Business WireIllumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand - Business Wire
businesswire.com - May 31 at 7:17 PM
Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in ThailandIllumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand
finance.yahoo.com - May 31 at 7:17 PM
Is It Too Late to Buy Illumina (ILMN) Stock? - Yahoo Finance AustraliaIs It Too Late to Buy Illumina (ILMN) Stock? - Yahoo Finance Australia
finance.yahoo.com - May 28 at 1:38 PM
Illumina Battles U.S., European Antitrust Enforcers on Grail Deal - The Wall Street JournalIllumina Battles U.S., European Antitrust Enforcers on Grail Deal - The Wall Street Journal
wsj.com - May 28 at 1:38 PM
Is It Too Late to Buy Illumina (ILMN) Stock?Is It Too Late to Buy Illumina (ILMN) Stock?
finance.yahoo.com - May 28 at 1:38 PM
Illumina (ILMN) Down 1.9% Since Last Earnings Report: Can It Rebound? - Yahoo FinanceIllumina (ILMN) Down 1.9% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
finance.yahoo.com - May 28 at 12:23 AM
Illumina (ILMN) Down 1.9% Since Last Earnings Report: Can It Rebound? - NasdaqIllumina (ILMN) Down 1.9% Since Last Earnings Report: Can It Rebound? - Nasdaq
nasdaq.com - May 27 at 2:22 PM
Illumina (ILMN) Down 1.9% Since Last Earnings Report: Can It Rebound?Illumina (ILMN) Down 1.9% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - May 27 at 2:22 PM
Is Illumina (ILMN) Outperforming Other Medical Stocks This Year? - Yahoo FinanceIs Illumina (ILMN) Outperforming Other Medical Stocks This Year? - Yahoo Finance
finance.yahoo.com - May 27 at 9:21 AM
Is Illumina (ILMN) Outperforming Other Medical Stocks This Year? - NasdaqIs Illumina (ILMN) Outperforming Other Medical Stocks This Year? - Nasdaq
nasdaq.com - May 25 at 1:44 PM
Is Illumina (ILMN) Outperforming Other Medical Stocks This Year?Is Illumina (ILMN) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - May 25 at 1:44 PM
Should Weakness in Illumina, Inc.s (NASDAQ:ILMN) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - Yahoo FinanceShould Weakness in Illumina, Inc.'s (NASDAQ:ILMN) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - Yahoo Finance
finance.yahoo.com - May 22 at 1:22 PM
Should Weakness in Illumina, Inc.s (NASDAQ:ILMN) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?Should Weakness in Illumina, Inc.'s (NASDAQ:ILMN) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
finance.yahoo.com - May 22 at 1:22 PM
Gene-Sequencing Company With Several Illumina Execs at Top Going Public - Yahoo FinanceGene-Sequencing Company With Several Illumina Execs at Top Going Public - Yahoo Finance
finance.yahoo.com - May 19 at 2:26 AM
Questor: Illumina cracked the Covid code and tracks the variants – but that’s not why it’s a buyQuestor: Illumina cracked the Covid code and tracks the variants – but that’s not why it’s a buy
uk.finance.yahoo.com - May 18 at 9:18 PM
This page was last updated on 6/18/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.